in PS1 (-/-) neurons. In addition, chelating intracellular Ca 2+ with BAPTA produced an increase in Ca 2+ current amplitude that was comparable to the increase caused by PS1-deficiency. In contrast to this, BAPTA had no effect on voltage-dependent Ca 2+ conductances in PS1-deficient neurons. These data suggest that PS1-deficiency may influence voltage-gated Ca 2+ channel function by means that involve intracellular Ca 2+ signaling. These findings reveal that PS1
functions at multiple levels to regulate and stabilize intracellular Ca 2+ levels that ultimately control neuronal firing behavior and influence synaptic transmission.
INTRODUCTION
Presenilin 1 and 2 (PS1 and PS2, respectively) are ubiquitously expressed polytopic membrane-spanning proteins that are best appreciated for their role in regulating cleavage of the Amyloid Precursor Protein (APP) to produce the Alzheimer's disease related peptide, A-beta (A , Doan et al. 1996; Li and Greenwald 1996; Haass 1997) . Early onset Familial Alzheimer's Disease (FAD) is associated with more than one hundred presenilin mutations, the vast majority of which occur in PS1 (Rogaev et al. 1995; Sherrington et al. 1995; Levy-Lahad et al. 1995; Selkoe 1997) . PS1 also regulates cleavage of Notch (Levitan et al. 1996; Baumeister et al. 1997; Struhl and Greenwald 1999) , Delta1 and Jagged2 (Ikeuchi and Sisodia 2003) , ErbB-4 (Ni et al. 2001 ), E-cadherin (Marambaud et al. 2002) , LDL receptor-related protein (May et al. 2002) , and Na + channel subunits (Kim et al. 2005; Wong et al., 2005) ; and regulates protein trafficking (Naruse et al. 1998; Leem et al. 2002; Cai et al. 2002) , apoptosis (Mattson et al. 1998; Wolozin et al. 1998) , and experience-dependent neurogenesis (Feng et al. 2001 ). In addition, several laboratories have reported that PS1 plays an important role in regulating intracellular Ca 2+ homeostasis involving endoplasmic reticulum Ca 2+ stores (Ito et al. 1994; Begley et al. 1999; Guo et al. 1999a; Leissring et al. 1999a Leissring et al. , 1999b Yoo et al. 2000; Herms et al. 2003; Stutzmann et al. 2004) . PS1-deficiency (-/-) significantly impairs intracellular Ca 2+ homeostasis (Yoo et al. 2000 ; Leissring et al. 2002; Yang and Cook 2004) . This defect is attributable to reduced levels of Ca 2+ release from inositol 1, 4,5-trisphosphate (IP 3 )-sensitive intracellular stores (Leissring et al. 1999b (Leissring et al. , 2002 (Leissring et al. , 2000 LaFerla 2002) .
A great deal of effort has been expended to further characterize and understand the role of PS1 in regulating intracellular Ca 2+ homeostasis and much has been learned. However, there is currently little evidence to suggest that PS1 also influences Ca 2+ homeostasis via plasma 3 membrane Ca 2+ channels. Therefore, the goal of the present work was to examine whether the alterations in Ca 2+ homeostasis in PS-1 deficient mice include any changes in the voltagedependent Ca 2+ current carried by plasma membrane channels. Using primary cultured cortical neurons derived from PS1 wild-type (+/+) and PS1 knock-out (-/-) mice (Shen et al. 1997 
METHODS

Generation of PS1-Deficient Mice
Embryonic mice derived from PS1 doubly heterozygous (+/-) crosses were genotyped using three PCR primers (primer 1: 5'-ACCTCAGCTGTTTGTCCCGG-3', primer 2: 5'-GCACGAGACTAGTGAGACGTG-3' and primer 3: 5'-CTGGAAGTAG-GACAAAGGTG-3').
Primers 1 and 3 generated a 345 base pair (bp) PCR product diagnostic of a wild type genotype, whereas primers 1 and 2 yielded a 300 bp band indicating a knock-out genotype (Shen et al 1997) . Experiments were performed using PS1 (-/-) mice backcrossed into a C57BL6 genetic background more than ten generations.
Primary Neuronal Culture
These experiments were performed using aged matched cortical neurons from embryonic mice maintained in primary culture. All animal protocols were reviewed and approved by the supplemented with B-27 (1:50), glutamine (0.5 mM) and PenStrep (100 U/ml). Neurons were studied after being maintained in culture for 10-12 days to allow time for the normal developmental up-regulation of voltage-gated Ca 2+ channels (Lorenzon and Foehring 1995; Foehring and Lorenzon 1999) .
Whole-cell (WC) recordings
Standard whole-cell voltage clamp recording techniques were employed to record wholecell Ca 2+ current from visually identified cortical neurons with pyramidal morphology and relatively short processes (Surmeier et al. 1992 channels. Electrodes were pulled from micropipette glass and fire-polished prior to use.
Electrode resistances were normally 3-6M and final series resistance values averaged 6-8M .
Series resistance compensation of (80%) was routinely employed. Recordings were obtained using an Axon Instruments 200B patch clamp. Voltage pulses were delivered and currents were recorded using a personal computer running pClamp software to control AD/DA interface.
Drugs were applied using a motor driven "sewer pipe" system that allowed rapid solution changes. The perfusion array was located a few hundred microns away from the cell under study. When using -agatoxin IVA, cytochrome C (Calbiochem; San Diego, CA) was added to all solutions (0.01%) to prevent nonspecific binding to plastics. Concentrated stocks of nifedipine (Sigma RBI; St. Louis, MO) were made in 100% ethanol, aliquoted and frozen prior to use.
Ethanol and cytochrome C vehicle controls were performed where necessary.
Data Analysis
Data were collected using standard voltage step or voltage ramp protocols. Whole-cell currents were elicited by a series of 300 ms depolarizing test pulses in the range of -70 to 50 mV from a holding potential of -110. Conductance (g) was calculated from peak current where
, where I was the current, V was the test pulse voltage, and V rev was the measured 7 reversal potential. Conductance-voltage curves were fit with a Boltzmann function of the form:
where V.5 was the half activation voltage, k was the slope factor and g max was the maximum conductance. Least-squares curve fitting and statistical analysis were done using Sigma Plot (SPSS, Inc., Chicago, IL) and Origin (Microcal, Northampton, MA).
Statistics are presented as means + SEM. Statistical significance was established by student's t test or one-way ANOVA followed by post-hoc Sheffe' analysis with p values as reported.
RESULTS
We examined the physiological properties of the whole-cell high-voltage activated (HVA) Ca 2+ current in PS1-wild type (+/+), PS1-heterozygous (+/-), and PS1-deficient (-/-) cortical neurons at DIV 10-12. Whole-cell current was elicited by a series of depolarizing test pulses in the range of -70 to +50 mV from a holding potential of -110 mV ( Figures 1A and 1B) .
In most cells, the current was exclusively of the HVA type. suggesting a gene dosage effect of PS1.
One possible explanation for this observation is that the increase in peak current amplitude was due to increased cell size in the PS1 (-/-) neurons. To rule out this possibility, we assessed cell size utilizing membrane capacitance measures. Membrane capacitance is defined as the amount of charge across the membrane bilayer and is therefore a good determinant of membrane area. A larger membrane surface area results in a larger membrane capacitance value.
If PS1 (-/-) neurons were larger, then the membrane capacitance values would be expected to be larger for this population of neurons. However, we found no significant difference in the membrane capacitance values among the three populations ( Figure 1E ; 10.1 + 0.5 pF (n=71) for PS1 (+/+) neurons vs. 9.9 + 0.4 pF (n=94) for PS1 (-/-) neurons; p=N.S.; one-way ANOVA).
PS1 (+/-) neurons had a similar membrane capacitance value of 11.3 + 0.7 pF (n=28). To further insure that our findings were not influenced by cell size variations, we normalized our peak current data by cell size using individual cell capacitance measures to determine peak current density (pA/pF). As shown in Figure 1F , peak current density was significantly different across the three groups (one-way ANOVA, p=.00001). Peak current density was significantly 
S.).
We next attempted to determine whether the current density of particular classes of HVA Ca 2+ channels is increased in the PS1 (-/-) neurons. Pharmacological studies have identified 5
types of HVA channels in central neurons. These include N-, L-, P-, Q-and R-type channels (Tsien et al. 1991) , all of which appear to represent distinct gene families and are expressed to various degrees in cortical neurons in this age range (Snutch et al. 1990; Snutch and Reiner 1992; Zhang et al. 1993; Randall and Tsien 1995 blockers, therefore, the contribution of R-type currents was defined as any current remaining in the presence of blockers for all the other channel subtypes.
One or more of these channel blockers were applied sequentially to each cell in the following order: Nifedipine (5 µM), -Conotoxin GVIA (1 µM), -Agatoxin IVA (100 nM) and -Conotoxin MVIIC (2 µM). We were able to apply all four blockers in some but not every cell so the n-values vary for each blocker. L-type current was defined as the component of the wholecell current that was sensitive to block by 5µM nifedipine. N-type current was defined as the component of the remaining whole-cell current sensitive to block by 1 µM -Conotoxin GVIA.
P-type current was defined as the component of the remaining whole-cell current sensitive to block by 100 nM -Agatoxin IVA. Q-type current was defined as the component of the remaining whole-cell current sensitive to block by 2 µM -Conotoxin MVIIC. Since N-and Ptype currents were already blocked, the effects of -Conotoxin MVIIC on those current types did not confound our data. MVIIC-sensitive currents were only assessed in cells where -Conotoxin GVIA and -Agatoxin IVA were already applied. R-type current was defined as the component of the current remaining in the presence of all four blockers. Each blocker was applied and the peak current amplitude was allowed to stabilize for 2-4 minutes prior to data acquisition. Peak current was monitored periodically during drug application by a ramp voltage protocol from -110 mV to +50 mV @ 0.5 mV/ms. Following stabilization of the peak current amplitude in the drug solution, data acquisition began. The next blocker was then added and the current was allowed to stabilize again prior to data acquisition. In control cells, current rundown was typically less than 10% and followed a linear progression during an experiment of similar duration using identical voltage protocols.
We first tested whether the increase in total current involved a specific increase in L-type current by examining the size of the nifedipine-sensitive current. If the percentage of the wholecell current carried by L-type Ca 2+ channels is increased in the PS1-deficient neurons, the percentage of the current blocked by the dihydropyridine, nifedipine (5 µM) should be increased in these neurons as well. As shown in Figure 2A -D, our pharmacological analysis supported this hypothesis and demonstrated that PS1 (-/-) neurons were more sensitive to block by 5 µM nifedipine, suggesting a specific increase in L-type Ca 2+ current amplitude. For PS1 (+/+) neurons, the percentage of the whole-cell current blocked by nifedipine was 33.8 + 2.5% (n=31) compared to 44.4 + 2.4 % (n=37; p=0.003, Student's t test) for PS1 (-/-) neurons ( Figure 2C ). A similar result was obtained when the total current blocked by nifedipine was analyzed. For PS1 (+/+) neuron the total current blocked by nifedipine was 101.8 + 9.2 pA (n=31) compared to 165.8 + 15.1 pA for PS1 (-/-) neurons (n=37; p=0.001, Student's t test).
To address the possibility that HVA Ca 2+ channel subtypes in addition to L-type contribute to the phenotype of increased whole-cell HVA Ca 2+ current in PS1-deficient neurons, we conducted pharmacological experiments designed to isolate P-, N-, Q-and R-type channels as described above. Using the P-type specific Ca 2+ channel blocker, -Agatoxin IVA (100 nM) we found that the percentage of the whole-cell current carried by P-type Ca 2+ channels is increased in the PS1-deficient neurons as well. As shown in Figures 2E and F, Using the additional specific Ca 2+ channel blockers, -Conotoxin GVIA (1 µM; N-type) and -Conotoxin MVIIC (2 µM; Q-type), we found no significant changes in the amplitudes of N-or Q-type channels as summarized in Table 1 . The contribution of R-type or resistant channels was also unchanged.
Since PS1-deficiency (-/-) significantly impairs intracellular Ca 2+ homeostasis (Yoo et al. 2000; Leissring et al. 2002; Yang and Cook 2004) , we were interested in the relationship between decreased intracellular Ca 2+ stores and the observed alterations in Ca 2+ current amplitude. Therefore, we repeated these experiments under several conditions in which intracellular Ca 2+ levels could be experimentally manipulated. In the first set of experiments, we repeated the original experiment described in Figure 1 in the presence of 10 mM intracellular BAPTA. This concentration of BAPTA is sufficient to buffer any intracellular Ca 2+ signal. If the observed increase in Ca 2+ current amplitude is related to PS1-dependent impairment of intracellular Ca 2+ signaling, then we predicted that WT PS1 (+/+) neurons recorded in the presence of 10 mM BAPTA would have a whole-cell Ca 2+ current phenotype that was similar to 13 untreated PS1 (-/-) neurons. We further predicted there would be no effect of this experimental manipulation on the PS1-deficient neurons since the intracellular Ca 2+ level was already reduced in these neurons. As shown in Figure 3, Figure 3A ). Chelation of intracellular Ca 2+ with BAPTA produced an increase in Ca 2+ current amplitude that was comparable to the increase caused by PS1-deficiency ( Figure   3A ). By contrast, there was no effect of 10 mM BAPTA on peak current amplitude in the PS1 (-/-) population ( Figure 3A , p=N.S., Scheffe' test). Average peak current density in the BAPTA treated WT PS1 (+/+) neurons was also significantly larger relative to untreated WT PS1 (+/+) neurons (52.4 + 4.4 pA/pF; n=22 vs. 29.6 + 2.0 pA/pF; n=71; p<0.005, Scheffe' test; Figure 3C ).
There was no effect of 10 mM BAPTA on peak current density in the PS1 (-/-) population ( Figure 3C , p=N.S., Scheffe' test).
The use of caffeine offers another well-established experimental manipulation to alter intracellular Ca 2+ homeostasis and we tested whether the effects of caffeine were different in the PS-1 deficient mice. To test this idea, we chronically exposed WT PS1 (+/+) neurons to 500 µM caffeine for 10-12 hours prior to the electrophysiology experiment. Caffeine exposure was maintained during the electrophysiology experiment by the inclusion of 500 µM caffeine in the background solution and the external recording solution. This treatment should result in the chronic depletion of Ca 2+ from intracellular stores. Again, if the observed increase in Ca 2+ current amplitude is related to PS1-dependent impairment in intracellular Ca 2+ signaling, then we predicted that WT PS1 (+/+) neurons that have been chronically exposed to caffeine should have a whole-cell Ca 2+ current phenotype that is similar to PS1 (-/-) neurons. As shown in Figure 4 , this was indeed the case. WT PS1 (+/+) neurons that were been chronically exposed to 500 µM caffeine had a peak current amplitude that was significantly larger relative to untreated WT PS1 (+/+) neurons (434.4 + 55.7 pA; n=23 vs. 270.7 + 16.5 pA; n=71; p<0.005, Scheffe' test; Figure   4A . Chronic caffeine exposure produced an increase in Ca 2+ current amplitude that was comparable to the increase caused by PS1-deficiency ( Figure 4A ). By contrast, there was no effect of caffeine treatment on peak current amplitude in the PS1 (-/-) population ( Figure 4A, p=N.S., Scheffe' test). Average peak current density in the caffeine treated WT PS1 (+/+) neurons was also significantly larger relative to untreated WT PS1 (+/+) neurons (41.7 + 4.5 pA/pF; n=23 vs. 29.6 + 2.0 pA/pF; n=71; p<0.005, Scheffe' test; Figure 4B ). There was no effect of caffeine treatment on peak current density in the PS1 (-/-) population ( Figure 4B , p=N.S., Scheffe' test). More specifically, the magnitude of L-type Ca 2+ current was increased in the caffeine treated PS1 WT (+/+) neurons to a level similar to that observed for the untreated PS1 (-/-) neurons as shown in Figure 5 . We observed no effect of chronic caffeine exposure on the magnitude of the L-type Ca 2+ current in the PS1 (-/-) neurons ( Figure 5 ).
DISCUSSION
Our results provide strong evidence suggesting that PS1-deficiency alters the activity of 
Potential mechanisms for the upregulation of L-and P-type Ca 2+ channel activity
The mechanism by which PS1-deficiency increases Ca 2+ channel activity in cultured cortical neurons is not clear but our data allow us to speculate on several potential mechanisms.
First, it has been recently reported that the -subunit of the voltage gated Na + channel is a target for PS1/ -secretase dependent cleavage (Kim et al. 2005; Wong et al. 2005) . Although PS1-dependent cleavage of a Ca 2+ channel subunit has not yet been reported in the literature, it is possible that one or more of the subunits comprising the L-and P-type Ca 2+ channels may be substrates for PS1-dependent cleavage resulting in alterations in channel function. It has been reported that neuronal class C L-type Ca 2+ channels are proteolytically cleaved by calpain resulting in full-length and short isoforms with different functional properties (Hell et al. 1993; Wei et al. 1994; Klöckner et al. 1995; Hell et al. 1996) . The full-length isoform gives rise to a channel with 4-6 fold lower conductance than the short-form, which is truncated at the Cterminus (Wei et al. 1994; Klöckner et al. 1995) . It is conceivable that PS1 might similarly cleave the L-type Ca 2+ channel in cortical neurons. However, if this was the case, one would expect the full-length form to be most abundant in PS1-deficient neurons, resulting in reduced peak current amplitude. However, peak Ca 2+ current amplitude is increased in PS1-deficient neurons, not decreased. Therefore, it is unlikely that PS1-dependent cleavage of the channel protein can account for our findings.
Second, Ca 2+ channel expression in the plasma membrane may be upregulated as a result of PS1-deficiency. This possibility cannot be ruled out based upon our current data, however, the new channels would have to available in a pool near the plasma membrane, awaiting rapid insertion based upon the data obtained in our recordings of wild-type neurons dialyzed with 10 mM BAPTA. In these experiments, Ca 2+ current amplitude was increased to PS1 (-/-) levels within a time frame less than our five-minute dialysis period. This time frame would appear too rapid for the generation and insertion of new channel proteins but does not rule out a readily available pool of channels. Future experiments aim to address this issue more fully using immunohistochemistry and/or western blotting approaches.
Third, the PS1-dependent decrease in intracellular Ca 2+ levels may alter the activity of voltage-gated plasma membrane Ca 2+ channels. It is well established that intracellular Ca 2+ plays a pivotal role in regulating a number of critical functions in the central nervous system (CNS)
including axonal outgrowth and targeting, learning and memory, neuronal excitation, and neurotransmitter release (Forscher 1989; Catterall 1999; Rizzuto 2001; Rose and Konnerth 2001) . Ion channel activity is also regulated by intracellular Ca 2+ signals. As a specific example, L-type Ca 2+ channels are strongly inhibited following activation of a subset of muscarinic acetylcholine receptors coupled to phospholipase C (PLC) activation and subsequent release of IC Ca 2+ from IP 3 -sensitive stores (Howe and Surmeier 1995; Stewart et al. 1999 ). Therefore, it is possible that the observed changes in Ca 2+ channel activity may result from reduced intracellular Ca 2+ signals in the PS1 (-/-) neurons. Our BAPTA and caffeine data would support this idea and suggest that PS1-dependent dysregulation of intracellular Ca 2+ homeostasis is intimately related to the increase in peak current amplitude.
Finally, since PS1 effects a variety of other pathways including development, protein trafficking, apoptosis and neurogenesis, it must be considered that the effects of PS1-deficiency on voltage-gated Ca 2+ channel activity may be via a much more indirect chain of events.
Functional Significance of HVA Ca 2+ Channel Regulation
HVA Ca 2+ channels are the primary regulators of excitability and input integration at the cell soma and dendrites and contribute to neurotransmitter release at synapses in the central nervous system (Catterall 2000; Meir et al. 1999; Hille 2001) . At the soma, voltage-gated L-type Ca 2+ channels help to maintain longer lasting depolarizations to reduce firing threshold and regulate repetitive firing as well as shaping regenerative action potentials. In addition, Ca 2+ flux via L-type HVA Ca 2+ channels localized at the soma has been show to regulate gene transcription (Gallin and Greenberg 1995; Finkbeiner and Greenberg 1998) . Voltage-gated P-type Ca 2+ channels initiate neurotransmission at fast synapses (Catterall et al., 2000) . 
Significance of PS1 in Regulating Calcium Signaling
A growing number of studies argue that PS1 regulates intracellular Ca 2+ signaling. Every FAD-related PS1/2 mutation that has been examined displays altered intracellular Ca 2+ signaling (LaFerla 2002) . Regarding PS1 FAD mutations, the data are consistent with the idea that Ca 2+ levels in the endoplasmic reticulum (ER) are elevated (Guo et al. 1996 (Guo et al. , 1999b (Guo et al. , 1999a Parent et al. 1999; Begley et al. 1999; Leissring et al. 1999a Leissring et al. , 2000 Leissring et al. , 2002 Yoo et al. 2000; Schneider et al. 2001; Herms et al. 2003; Stutzmann et al. 2004) . Conversely, PS1-deficiency leads to lower Ca 2+ levels in the ER (Leissring et al. 2002; Nakajima et al. 2001 ). PS2-deficient cells, by contrast, display no defect in intracellular Ca 2+ homeostasis (Leissring et al. 2002) . Importantly, new findings strongly suggest that APP metabolism may play a significant role in mediating the effects of PS1 on intracellular Ca 2+ signaling. Gamma-secretase inhibitors, which block PS1 activity (Wolfe 2001) , reduce both A production and ER Ca 2+ stores. Also, APP-deficiency appears to mimic the effects of PS1 deficiency on ER Ca 2+ levels (Leissring et al. 2002) . Thus on one hand, reduced intracellular Ca 2+ levels are associated with reduced levels of A , while on the other hand, evoking Ca 2+ increases (Querfurth and Selkoe 1994) A large literature uniformly supports the idea that intracellular calcium signaling is influenced by PS1 function (Ito et al. 1994; Begley et al. 1999; Guo et al. 1999a; Leissring et al. 1999a Leissring et al. , 1999b Leissring et al. , 2002 Yoo et al. 2000; LaFerla, 2002; Herms et al. 2003; Stutzmann et al. 2004; Yang & Cook, 2004) and has been validated using a wide variety of preparations including, Xenopus oocytes (Leissring et al. 1999b) , fibroblasts (Leissring et al, 2002) , neurons (Yoo et al 2000 , Yang & Cook 2004 , and hippocampal slices (Herms et al 2003) . Overall the findings from different labs are quite concordant. Yet, there are differences, as well. For example, in slices intracellular stores have been reported to increase in PS1 KO neurons, rather than decrease as observed by us (Yang & Cook, 2004) and others (Yoo et al., 2000) . Although it is possible such differences are due to methodological issues, a more interesting possibility arises from the implications of the data reported herein. Our findings show that PS1 deficiency increases the entry of calcium from extracellular sources. Yet, we and others have also reported that PS1 deficiency reduces cytoplasmic calcium signals derived from intracellular calcium stores (Yoo et al., 2000 , Yang & Cook, 2004 . We interpret these data to show that impaired intracellular calcium signaling leads to a compensatory increase in calcium entry mediated by voltage-gated calcium channels. It is quite likely that the compensatory action of voltage-gated calcium channels in PS1 KO neurons is attenuated in younger neuronal cultures where the expression of these channels is delayed. By waiting to carry out our experiments in more mature neurons we were able observe the effects of PS1 deficiency on calcium channels, while in younger cultures the effects of PS1 deficiency on ER calcium stores could be revealed with less apparent opposition from extracellular calcium sources. Thus, it is possible that the intracellular calcium response observed in PS1 neuronal KO slices (Herms et al., 2003) were mediated by changes in the influx of calcium from extracellular sources. (Nakajima et al. 2001) . One possible functional consequence of such processes is that the normal activity of PS1 may limit the neurotoxicity mediated by HVA Ca 2+ channels in response to a variety of toxic insults thought to be associated with multiple neurodegenerative disorders, as well as aging. 
